The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.
Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection Update
The Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection have been updated.
The Pediatric Guidelines, developed by the Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children, now include Supplement II, titled "Managing Complications of HIV Infection in HIV-Infected Children on Antiretroviral Therapy, "and Supplement III, titled "Adverse Drug Effects." Also included in the new version are updates to the atazanavir, indinavir, and enfuvirtide sections in Supplement I, "Pediatric Antiretroviral Drug Information."
All new information is highlighted in yellow in the main document. Supplements II and III are new to the guidelines and are highlighted in title only.
The updated guidelines document is available in the Pediatric Guidelines section (http://aidsinfo.nih.gov/guidelines/default_db2.asp?id=51) of the Guidelines page on the AIDSinfo Web site.
HIV/AIDS Program Director
Office of Special Health Issues
Food and Drug Administration